Comparing Techniques for Detecting Hormone Receptors in Breast Cancer
Author Information
Author(s): KD Amoils, L Seymour, WR Bezwoda
Primary Institution: University of the Witwatersrand
Hypothesis
Is PCR a viable method for detecting estrogen receptors and transforming growth factor in breast cancer tissue?
Conclusion
PCR is a reliable method for detecting both estrogen receptors and transforming growth factor in breast cancer samples.
Supporting Evidence
- 70 confirmed breast carcinoma samples were analyzed for estrogen receptors using both techniques.
- 19 out of 70 samples were found to be ER positive by both methods.
- PCR showed 100% specificity and sensitivity for TGF-β detection.
Takeaway
This study shows that a special test called PCR can help doctors find important markers in breast cancer samples, which can help in understanding the disease better.
Methodology
The study analyzed breast cancer samples using both PCR and immunocytochemical techniques to detect estrogen receptors and transforming growth factor.
Limitations
Some samples did not contain malignant cells, which could affect the overall results.
Participant Demographics
{"mean_age":52,"premenopausal":30,"post_menopausal":40,"black":42,"caucasian":28,"stage_4":40}
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website